– Late-breaking abstract on extended follow-up data from the MATCH Phase 2 trial accepted for poster presentation – – Poster presentation on new data highlighting the Company’s discovery platform to differentiate, engineer and cryopreserve macrophages for therapeutic use – EDINBURGH,…